Kishan and colleagues found that men with PSA levels of 0.51-1.00 ng/mL had a reduction in mortality risk with the addition of hormone therapy (HR 0.72, 95% CI 0.54-0.96), as did those with PSA levels ...

The 59.4% real-world pain responder rate from the use of inFoods® IBS closely mirrors the 59.6% result from the controlled trial-offering an unusual degree of consistency between controlled and ...

Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...

Bridgebio Pharma Inc. disclosed positive top-line results from Propel 3, the global phase III pivotal study of oral infigratinib in children with achondroplasia. Change from baseline in annualized ...

Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...

Q4 2025 Management View CEO Robert Ragusa reported "2025 was a year of significant commercial growth for GRAIL," highlighting the issuance of top line results from the NHS-Galleri trial, which showed ...

Objectives Since 1985, the international healthcare community has recommended the ideal rate of caesarean section (CS) to be 10%–15% at the national level. The literature has reported that overused CS ...

The digital health sector reached a significant turning point when Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: ...

Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 Million Completed Galleri PMA Submission to FDA Shared Topline ...

Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...

An informational overview examining category context, publicly available product disclosures, and what consumers often consider when researching wearable health monitoring device options in 2026 - ...